As such, we used dissociated SGNs as a means to evaluate natively expressed Trk receptor responses by assessing their survival, an endpoint that is relevant for the potential clinical use of neurotrophins in inner ear disorders. This evidence concerns the gene BDNF and inner ear disorder.